Ft. Myers, Fl., USA - April 24, 2015, Ft. Myers, Fl., USA - NeoGenomics, Inc., a provider of cancer-focused genetic testing services, announced several promotions within the company's senior management team.
Article continues below
Sally Agersborg, M.D., Ph.D., Director of Hematopathology and Medical Director, Irvine
Dr. Agersborg joined NeoGenomics in 2011 as a Hematopathologist and currently serves as Medical Director, Irvine. Prior to joining NeoGenomics, Dr. Agersborg worked as a Hematopathologist at Quest Diagnostics Nichols Institute.
She received her B.S. degree and M.S. degrees from Stanford, earned a combined M.D. in Medicine and Ph.D. in Microbiology from the University of Virginia, and completed her post-graduate medical training in Anatomic Pathology at the University of California, San Francisco.
Jennifer Balliet, Vice President of Human Resources
Ms. Balliet joined NeoGenomics in 2008 and has steadily increased her responsibilities and importance to our company and currently serves as Director of HR. She received her B.S. degree in Psychology and M.S. degree in Business Management from the University of Florida.
Steven Brodie, Ph.D., Chief Scientific Officer and Medical Director, Fort Myers
Dr. Brodie joined NeoGenomics in 2011 as Director of Cytogenetics in Fort Myers and currently serves as Director of Molecular Genetics and Cytogenetics, Florida. Prior to joining NeoGenomics, he served as Senior Director of Cytogenetics, and Assistant Director of Molecular Genetics at Specialty Laboratories/Quest Diagnostics in Valencia CA.
He has held various research and clinical positions at the NIH, University of New Mexico school of Medicine, and UCLA David Geffen school of Medicine. ■
Modified arctic air combined with a moisture-laden area of low pressure along the Gulf Coast will continue to allow for a broad area of winter weather impacts from the Lower Mississippi Valley to the Southeast today into early Saturday morning.